WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted antibody-based anticancer products, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, April 27, 2012, to discuss ImmunoGen’s financial results for the three-month period ended March 31, 2012 – the third quarter of the Company’s 2012 fiscal year. Management also will provide an update on the Company.
